Brief: Advaxis Reports Qtrly Loss Per Share Of $0.02
Sept 10 (Reuters) - Advaxis Inc ADXS.O :
* ADVAXIS REPORTS 3RD QUARTER ENDED JULY 31, 2021 FINANCIAL
RESULTS AND PROVIDES A BUSINESS UPDATE
* ADVAXIS - AS OF JULY 31, 2021, CO HAD ABOUT $45.3 MILLION
IN
CASH AND CASH EQUIVALENTS
* ADVAXIS INC QTRLY LOSS PER SHARE $0.02
Source text for Eikon: ID:nGNX48RZ5y
Further company coverage: ADXS.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Ayala Pharmaceuticals
See all newsBrief: Ayala Pharmaceuticals Completes Sale Of AL102 To Immunome
Immunome slides on $200 mln equity offering
Immunome edges up after $200 mln equity offering
Brief: Immunome To Acquire AL102 Phase 3 Asset for the Treatment of Desmoid Tumors From Ayala Pharmaceuticals
Brief: Ayala Pharmaceuticals Announces AL102 Receives Orphan Drug Designation for Desmoid Tumors